• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SD filed by Cardinal Health Inc.

    5/22/25 8:34:09 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care
    Get the next $CAH alert in real time by email
    SD 1 a2024formsd.htm SD Document

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM SD
    Specialized Disclosure Report
     
    Cardinal Health, Inc.
    (Exact name of the registrant as specified in its charter)
     
    Ohio 1-1137331-0958666
    (State or other jurisdiction of incorporation or organization) (Commission File Number)(I.R.S. Employee Identification No.)
    7000 Cardinal Place, Dublin, Ohio 43017
    (Address of principal executive offices) (Zip code)
    Jessica L. Mayer
    Chief Legal and Compliance Officer
    (614) 757-5000
    (Name and telephone number, including area code, of the
    person to contact in connection with this report.)
     
    Check the appropriate box to indicate the rule pursuant to which this Form is being submitted, and provide the period to which the information in this Form applies:
    þ
    Rule 13p-1 under the Securities Exchange Act (17 CFR 204.13p-1) for the reporting period from January 1 to December 31, 2024.
    ☐Rule 13q-1 under the Securities Exchange Act (17 CFR 204.13q-1) for the fiscal year ended ___________.





    Section 1 - Conflict Minerals Disclosure
    Item 1.01. Conflict Minerals Disclosure and Report
    Conflict Minerals Disclosure
    A copy of Cardinal Health, Inc.'s Conflict Minerals Report for the reporting period from January 1, 2024 to December 31, 2024 is filed as Exhibit 1.01 hereto and is publicly available on the company's website at https://www.cardinalhealth.com/en/about-us/environmental-social-governance/policies-and-principles.html. Information contained on our website is not incorporated by reference into this Form SD or the accompanying Conflict Minerals Report.

    Item 1.02. Exhibit
    A copy of the Conflict Minerals Report is attached hereto as Exhibit 1.01 and incorporated herein by this reference.

    Section 2 - Resource Extraction Issuer Disclosure
    Item 2.01. Resource Extraction Issuer Disclosure and Report
    Not applicable.
    Section 3 - Exhibits
    Item 3.01. Exhibits
    Exhibit No.Description
    1.01 
    Conflict Minerals Report for the reporting period from January 1, 2024 to December 31, 2024
    2


    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
    Cardinal Health, Inc.
    (Registrant)
    By:/s/ Jessica L. MayerDate: May 22, 2025
    Jessica L. Mayer
    Chief Legal and Compliance Officer

    3
    Get the next $CAH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CAH

    DatePrice TargetRatingAnalyst
    2/5/2025$140.00 → $150.00Hold → Buy
    Jefferies
    1/8/2025$130.00 → $144.00Hold → Buy
    TD Cowen
    1/7/2025$140.00In-line → Outperform
    Evercore ISI
    1/6/2025$132.00 → $145.00Neutral → Buy
    BofA Securities
    12/13/2024$101.00 → $127.00Underweight → Equal Weight
    Wells Fargo
    12/4/2024$139.00Outperform
    Mizuho
    2/26/2024$125.00Outperform
    Leerink Partners
    2/9/2024Hold → Buy
    Argus
    More analyst ratings

    $CAH
    SEC Filings

    See more
    • SEC Form SD filed by Cardinal Health Inc.

      SD - CARDINAL HEALTH INC (0000721371) (Filer)

      5/22/25 8:34:09 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • SEC Form 10-Q filed by Cardinal Health Inc.

      10-Q - CARDINAL HEALTH INC (0000721371) (Filer)

      5/1/25 8:53:18 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Cardinal Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - CARDINAL HEALTH INC (0000721371) (Filer)

      5/1/25 6:49:54 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care

    $CAH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cardinal Health upgraded by Jefferies with a new price target

      Jefferies upgraded Cardinal Health from Hold to Buy and set a new price target of $150.00 from $140.00 previously

      2/5/25 7:09:45 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Cardinal Health upgraded by TD Cowen with a new price target

      TD Cowen upgraded Cardinal Health from Hold to Buy and set a new price target of $144.00 from $130.00 previously

      1/8/25 7:36:58 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Cardinal Health upgraded by Evercore ISI with a new price target

      Evercore ISI upgraded Cardinal Health from In-line to Outperform and set a new price target of $140.00

      1/7/25 7:44:30 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care

    $CAH
    Financials

    Live finance-specific insights

    See more
    • Cardinal Health Board of Directors Approves Quarterly Dividend

      DUBLIN, Ohio, May 5, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2025, to shareholders of record at the close of business on July 1, 2025. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an op

      5/5/25 5:30:00 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Cardinal Health Reports Third Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook

      Revenue was flat at $54.9 billion; revenue increased 19% excluding the impact of the previously communicated customer contract expirationGAAP1 operating earnings were $730 million; GAAP diluted EPS was $2.10Non-GAAP operating earnings increased 21% to $807 million, driven by segment profit growth across all of the company's operating segments; non-GAAP diluted EPS increased 13% to $2.35Fiscal year 2025 non-GAAP EPS guidance2 raised and narrowed to $8.05 to $8.15, from $7.85 to $8.00GI Alliance announces expansion into urology specialty therapeutic areaDUBLIN, Ohio, May 1, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2025 revenues of $54.9 billion,

      5/1/25 6:45:00 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Cardinal Health Board of Directors Approves Quarterly Dividend

      DUBLIN, Ohio, Feb. 3, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5056 per share out of the Company's capital surplus. The dividend will be payable on April 15, 2025, to shareholders of record at the close of business on April 1, 2025. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nucle

      2/3/25 5:15:00 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care

    $CAH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Ramakrishna Sudhakar was granted 1,049 shares (SEC Form 4)

      4 - CARDINAL HEALTH INC (0000721371) (Issuer)

      3/18/25 4:24:07 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Director Musslewhite Robert W was granted 1,049 shares (SEC Form 4)

      4 - CARDINAL HEALTH INC (0000721371) (Issuer)

      3/18/25 4:20:20 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • New insider Ramakrishna Sudhakar claimed no ownership of stock in the company (SEC Form 3)

      3 - CARDINAL HEALTH INC (0000721371) (Issuer)

      3/11/25 4:11:05 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care

    $CAH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Carlisle Companies Announces Leadership Appointments

      Carlisle Companies Incorporated (NYSE:CSL) today announced the appointment of Christopher B. Gaskill as Vice President & General Counsel for the Company. In conjunction with this appointment, Scott C. Selbach will transition to a new role as Executive Vice President, Government Relations for the Company. Mr. Selbach will also remain Secretary of the Company. Both Mr. Gaskill and Mr. Selbach will report to Chris Koch, Carlisle's Chair, President & Chief Executive Officer. Prior to joining Carlisle, Mr. Gaskill served as Executive Vice President, Chief Legal Officer, and Secretary at Summit Materials, Inc. (NYSE:SUM), where he was responsible for the company's global legal functions and ensu

      5/16/25 4:05:00 PM ET
      $CAH
      $CSL
      $SUM
      $WU
      Other Pharmaceuticals
      Health Care
      Specialty Chemicals
      Industrials
    • Cardinal Health releases new report on the cell and gene therapy industry

      Analysis charts the emergence and future of advanced therapies DUBLIN, Ohio, May 7, 2025 /PRNewswire/ -- Today, Cardinal Health (NYSE:CAH) released its 2025 Advanced Therapies Report: Revolutionizing patient care – the promise and potential of cell and gene therapies, providing insights into the evolving landscape of cell and gene therapies (CGTs). This inaugural report is based on a comprehensive survey of more than 100 healthcare providers as well as interviews with subject matter experts and a patient who received CAR T-cell therapy, all of whom provide valuable insights in

      5/7/25 7:30:00 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Cardinal Health Board of Directors Approves Quarterly Dividend

      DUBLIN, Ohio, May 5, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2025, to shareholders of record at the close of business on July 1, 2025. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an op

      5/5/25 5:30:00 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care

    $CAH
    Leadership Updates

    Live Leadership Updates

    See more

    $CAH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Carlisle Companies Announces Leadership Appointments

      Carlisle Companies Incorporated (NYSE:CSL) today announced the appointment of Christopher B. Gaskill as Vice President & General Counsel for the Company. In conjunction with this appointment, Scott C. Selbach will transition to a new role as Executive Vice President, Government Relations for the Company. Mr. Selbach will also remain Secretary of the Company. Both Mr. Gaskill and Mr. Selbach will report to Chris Koch, Carlisle's Chair, President & Chief Executive Officer. Prior to joining Carlisle, Mr. Gaskill served as Executive Vice President, Chief Legal Officer, and Secretary at Summit Materials, Inc. (NYSE:SUM), where he was responsible for the company's global legal functions and ensu

      5/16/25 4:05:00 PM ET
      $CAH
      $CSL
      $SUM
      $WU
      Other Pharmaceuticals
      Health Care
      Specialty Chemicals
      Industrials
    • Robert Musslewhite and Sudhakar Ramakrishna to join Cardinal Health Board of Directors

      DUBLIN, Ohio, March 10, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors has elected Robert Musslewhite, former Chief Executive Officer of Definitive Healthcare Corp., and Sudhakar Ramakrishna, President and Chief Executive Officer of SolarWinds Corporation, as independent directors, effective March 7, 2025. With more than 20 years of leadership experience, including serving as CEO for two publicly traded companies, Mr. Musslewhite brings to the board unique expertise in advanced analytics, data, and technology across the healthcare e

      3/10/25 6:45:00 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • RPM Announces Appointment of Three New Board Members

      RPM International Inc. (NYSE:RPM) today announced the appointment of three individuals, Craig S. Morford, Christopher L. Mapes and Julie A. Beck, to its board of directors. These appointments reflect RPM's ongoing commitment to expanding the expertise, diversity and leadership capabilities of its board as the company continues to drive long-term growth and shareholder value. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250113146614/en/Christopher L. Mapes (Photo: Business Wire) The appointments of Mr. Morford and Mr. Mapes are effective immediately, and Ms. Beck's term is set to commence on April 7, 2025. With these additions,

      1/13/25 4:45:00 PM ET
      $AOS
      $CAH
      $LECO
      $NDSN
      Consumer Electronics/Appliances
      Consumer Discretionary
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)

      SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)

      2/13/24 5:01:02 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)

      SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)

      1/30/24 1:39:03 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)

      SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)

      2/14/23 12:37:58 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care